Target intelligence / Profile preview

Bacterial 50S ribosomal subunit L11–23S rRNA interface (GAC interface)

Target
GAC interface
Molecular classification
Ribonucleoprotein, Bacterial ribosome component, Other
01

Overview

The bacterial 50S ribosomal subunit L11–23S rRNA interface is a critical structural and functional component of the GTPase-associated center (GAC) within the prokaryotic ribosome [1.3.3, 1.3.5]. This interface is formed by the interaction of ribosomal protein L11 (uL11) with a highly conserved 58-nucleotide domain of the 23S rRNA, specifically helices H43 and H44 [1.2.1, 1.3.1]. Its primary biological role is to facilitate the binding and activation of essential translation factors, such as elongation factor G (EF-G) and elongation factor Tu (EF-Tu), which are necessary for protein synthesis [1.3.1, 1.3.3]. Specifically, the interface stimulates the ribosome-dependent GTPase activity of these factors, driving the translocation of mRNA and tRNAs [1.3.3, 1.3.5]. This site is the primary target for the thiopeptide class of antibiotics, including thiostrepton and micrococcin, which bind in a cleft between the L11 N-terminal domain and the rRNA [1.2.1, 1.3.1]. By binding here, these drugs stabilize a specific conformation of the ribosome that prevents the necessary transitions for factor turnover or stable factor binding, thereby halting bacterial translation [1.3.1, 1.3.5]. While highly effective in vitro, the clinical utility of drugs targeting this interface has been limited by poor solubility and pharmacokinetic challenges [1.3.1]. Consequently, it remains a significant focus for the development of next-generation antimicrobials designed to overcome these limitations [1.2.1, 1.4.4].

Other names
GTPase-associated centerGACL11-binding domainL11-23S rRNA complexThiopeptide binding site
02

Mechanism of action

Inhibition of translation elongation by preventing the stable binding and turnover of elongation factors (e.g., EF-G) on the ribosome [1.3.1, 1.3.3].

03

Biological functions

Protein synthesisTranslation elongationGTPase activationOther
04

Disease associations

Infection
05

Safety considerations

Poor aqueous solubility of thiopeptide antibiotics [1.3.1]Limited clinical bioavailability [1.3.1]Potential for rapid resistance development via target modification [1.2.2]
06

Interacting drugs

Thiostrepton

3 more in the full profile.

07

Biomarkers

23S rRNA methylation (e.g., by Tsr methyltransferase) [1.3.3]Ribosomal protein L11 mutations (e.g., P22L, P26L) [1.2.2]

Beyond the preview

Go deeper on Bacterial 50S ribosomal subunit L11–23S rRNA interface (GAC interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 50S ribosomal subunit L11–23S rRNA interface (GAC interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call